Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 25,101–25,150 of 25,420 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05155878	Prognostic Factors in Periampullary Tumors and Cysts	recruiting	—	500	Umeå UniversityOTHER	1	Jan 5, 2022	clinicaltrials
NCT05172310	PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI	recruiting	Phase 1	410	Karolinska University HospitalOTHER	1	Dec 29, 2021	clinicaltrials
NCT05172739